Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways

Overview

Journal Curr Issues Mol Biol

Publisher MDPI

Date 2025 Jan 24

PMID 39852178

Authors

Ciprian Puscasu

Corina Andrei

Octavian Tudorel Olaru

Anca Zanfirescu

Affiliations

Soon will be listed here.

Abstract

Chronic pain is a debilitating condition affecting millions worldwide, often resulting from complex interactions between the nervous and immune systems. Recent advances highlight the critical role of metabolite-sensing G protein-coupled receptors (GPCRs) in various chronic pain types. These receptors link metabolic changes with cellular responses, influencing inflammatory and degenerative processes. Receptors such as free fatty acid receptor 1 (FFAR1/GPR40), free fatty acid receptor 4 (FFAR4/GPR120), free fatty acid receptor 2 (FFAR2/GPR43), and Takeda G protein-coupled receptor 5 (TGR5/GPR131/GPBAR1) are key modulators of nociceptive signaling. GPR40, activated by long-chain fatty acids, exhibits strong anti-inflammatory effects by reducing cytokine expression. Butyrate-activated GPR43 inhibits inflammatory mediators like nitric oxide synthase-2 and cyclooxygenase-2, mitigating inflammation. TGR5, activated by bile acids, regulates inflammation and cellular senescence through pathways like NF-κB and p38. These receptors are promising therapeutic targets in chronic pain, addressing the metabolic and inflammatory factors underlying nociceptive sensitization and tissue degeneration. This review explores the molecular mechanisms of metabolite-sensing receptors in chronic pain, their therapeutic potential, and challenges in clinical application. By uncovering these mechanisms, metabolite-sensing receptors could lead to safer, more effective pain management strategies.

References

Chen C, Li H, Long Y . GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space. Bioorg Med Chem Lett. 2016; 26(23):5603-5612. DOI: 10.1016/j.bmcl.2016.10.074. View

Ge Y, Liao Q, Xu Y, Zhao Q, Wu B, Ye R . Anti-inflammatory signaling through G protein-coupled receptors. Acta Pharmacol Sin. 2020; 41(12):1531-1538. PMC: 7921558. DOI: 10.1038/s41401-020-00523-1. View

Karki P, Kurihara T, Nakamachi T, Watanabe J, Asada T, Oyoshi T . Attenuation of inflammatory and neuropathic pain behaviors in mice through activation of free fatty acid receptor GPR40. Mol Pain. 2015; 11:6. PMC: 4339434. DOI: 10.1186/s12990-015-0003-8. View

Chowdhury A, Nabila J, Adelusi Temitope I, Wang S . Current etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity. Pharmacol Res. 2020; 161:105102. DOI: 10.1016/j.phrs.2020.105102. View

Tanaka S, Miyagi T, Dohi E, Seki T, Hide I, Sotomaru Y . Developmental expression of GPR3 in rodent cerebellar granule neurons is associated with cell survival and protects neurons from various apoptotic stimuli. Neurobiol Dis. 2014; 68:215-27. DOI: 10.1016/j.nbd.2014.04.007. View

Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M . A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003; 278(11):9435-40. DOI: 10.1074/jbc.M209706200. View

Kelly M, Beuckmann C, Williams S, Sinton C, Motoike T, Richardson J . Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain. Proc Natl Acad Sci U S A. 2005; 102(28):9942-7. PMC: 1174999. DOI: 10.1073/pnas.0503795102. View

Dai C, Guo Y, Chu X . Neuropathic Pain: the Dysfunction of Drp1, Mitochondria, and ROS Homeostasis. Neurotox Res. 2020; 38(3):553-563. DOI: 10.1007/s12640-020-00257-2. View

Xiong Q, Huang H, Wang N, Chen R, Chen N, Han H . Metabolite-Sensing G Protein Coupled Receptor TGR5 Protects Host From Viral Infection Through Amplifying Type I Interferon Responses. Front Immunol. 2018; 9:2289. PMC: 6176213. DOI: 10.3389/fimmu.2018.02289. View

10.

Whitebread S, Dumotier B, Armstrong D, Fekete A, Chen S, Hartmann A . Secondary pharmacology: screening and interpretation of off-target activities - focus on translation. Drug Discov Today. 2016; 21(8):1232-42. DOI: 10.1016/j.drudis.2016.04.021. View

11.

Narasimhan M, Mahimainathan L, Reddy P, Benamar K . GPR18-NAGly system in periaqueductal gray and chronic neuropathic pain. Biochim Biophys Acta Mol Basis Dis. 2020; 1866(12):165974. DOI: 10.1016/j.bbadis.2020.165974. View

12.

Schafer R, Giancotti L, Davis D, Larrea I, Farr S, Salvemini D . Behavioral characterization of G-protein-coupled receptor 160 knockout mice. Pain. 2024; 165(6):1361-1371. PMC: 11090760. DOI: 10.1097/j.pain.0000000000003136. View

13.

Vilardaga J, Jean-Alphonse F, Gardella T . Endosomal generation of cAMP in GPCR signaling. Nat Chem Biol. 2014; 10(9):700-6. PMC: 4417940. DOI: 10.1038/nchembio.1611. View

14.

Kuner R, Kuner T . Cellular Circuits in the Brain and Their Modulation in Acute and Chronic Pain. Physiol Rev. 2020; 101(1):213-258. DOI: 10.1152/physrev.00040.2019. View

15.

Singh G, Maguire J, Kuc R, Fidock M, Davenport A . Identification and cellular localisation of NPW1 (GPR7) receptors for the novel neuropeptide W-23 by [125I]-NPW radioligand binding and immunocytochemistry. Brain Res. 2004; 1017(1-2):222-6. DOI: 10.1016/j.brainres.2004.03.079. View

16.

Sotudeh N, Morales P, Hurst D, Lynch D, Reggio P . Towards A Molecular Understanding of The Cannabinoid Related Orphan Receptor GPR18: A Focus on Its Constitutive Activity. Int J Mol Sci. 2019; 20(9). PMC: 6539512. DOI: 10.3390/ijms20092300. View

17.

Nakamura S, Nonaka T, Yoshida K, Yamada T, Yamamoto T . Neuropeptide W, an endogenous NPBW1 and NPBW2 ligand, produced an analgesic effect via activation of the descending pain modulatory system during a rat formalin test. Mol Pain. 2021; 17:1744806921992187. PMC: 7887691. DOI: 10.1177/1744806921992187. View

18.

Vane J, Botting R . Mechanism of action of aspirin-like drugs. Semin Arthritis Rheum. 1997; 26(6 Suppl 1):2-10. DOI: 10.1016/s0049-0172(97)80046-7. View

19.

Chen G, Staffen N, Wu Z, Xu X, Pan J, Inoue A . Structural and functional characterization of the endogenous agonist for orphan receptor GPR3. Cell Res. 2024; 34(3):262-265. PMC: 10907609. DOI: 10.1038/s41422-023-00919-8. View

20.

Chen G, Wang X, Ge Y, Ma L, Chen Q, Liu H . Cryo-EM structure of activated bile acids receptor TGR5 in complex with stimulatory G protein. Signal Transduct Target Ther. 2020; 5(1):142. PMC: 7400742. DOI: 10.1038/s41392-020-00262-z. View